A recombinant DNA vaccine encoding C. andersoni oocyst wall protein induces immunity against experimental C. parvum infection.

Jun Zheng,Wenzhi Ren,Qingshan Pan,Qiuyue Wang,I A Elfaki Elhag,Jianhua Li,Mingying Li,Pengtao Gong,Yingli Liu,Xichen Zhang

DOI: https://doi.org/10.1016/j.vetpar.2011.02.016

IF: 2.821

2011-01-01

Veterinary Parasitology

Abstract:Cryptosporidium andersoni parasited in the abomasum has been demonstrated as a cause of reduction of milk production in dairy cow. In this study, a novel chimeric DNA vaccine pVAX1-AB was constructed and the efficacy against Cryptosporidium parvum was determined. BALB/c mice were divided into 3 groups and immunized with DNA vaccine expressing the oocyst wall protein, AB protein of C. andersoni, the recombinant plasmid containing the AB gene, respectively. After inoculation of 1×106 oocysts of C. parvum, the humoral and cellular immune responses were detected. Experimental results showed that the recombinant plasmid can induce corresponding specific antibody response, simultaneously influenced cellular immune responses, and provided greater protection rate (48.6%) than the other groups. These results indicated that chimeric DNA vaccine has a potential in Cryptosporidium vaccine development.